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Abstract. The work studies ZrO2(MexOy)-based porous ceramics produced from the powders consisting of hollow 
spherical particles. It was shown that the structure is represented by a cellular framework with bimodal porosity 
consisting of sphere-like large pores and pores that were not filled with the powder particles during the compaction. For 
such ceramics, the increase of pore volume is accompanied by the increased strain in an elastic area. It was also shown 
that the porous ZrO2 ceramics had no acute or chronic cytotoxicity. At the same time, ceramics possess the following 
osteoconductive properties: adhesion support, spreading, proliferation and osteogenic differentiation of MSCs. 
INTRODUCTION 
Porous ceramic materials have been successfully used in various fields, including heat-insulating construction 
materials, because they are durable, corrosion resistant and they possess stable thermal features [1–3]. Porous 
ceramics are also a promising material for medical use in the field of traumatology and orthopedics for critical sized 
bone defect recovery. Thus porous ceramics can act both as osteoplastic material and as 3D scaffold for tissue-
engineered bone equivalent modeling [4]. 
Ceramics based on partially stabilized zirconium are the most interesting among the variety of ceramic materials 
due to their inherent high transformation toughening. It is known that the characteristics are determined by the 
quality of source ceramic powder (particle shape, particle size distribution), the compaction conditions, sintering 
mode, features of each phase and how these phases, including pores, are arranged in relation to each other. The most 
important factor in the successful application of materials is understanding the features of their structure and their 
behavior under mechanical impact. 
The aim of a paper is to examine the pore structure of ZrO2(MexOy) ceramics and its biocompatibility with 
multipotent stromal cells (mesenchymal stem cells, MSCs) by in vitro assays. 
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FIGURE 1. Plasmachemically-synthesized ZrO2 powders: (a) SEM-image of plasmachemically-synthesized ZrO2(Y2O3) powder, 
(b) particle size distribution of ZrO2(Y2O3) powder 
 
MATERIALS AND EXPERIMENTAL PROCEDURE 
The materials for the study were ceramics obtained from ZrO2(MgO) and ZrO2(Y2O3) powders produced by 
liquid-phase decomposition of precursors synthesized in high-frequency discharge plasma (the plasmachemical 
method).  
Porous ceramic ZrO2(MgO) and ZrO2(Y2O3) samples were prepared by compacting and subsequent sintering of 
compacts at the homologous temperatures ranging from 0.63 to 0.56 during the isothermal soaking for 1 to 5 hours. 
The porosity of ZrO2(MgO) and ZrO2(Y2O3) ceramics ranged from 15% to around 45% and from 30% to 80%, 
respectively. X-ray studies were carried out using a diffractometer with a CuK? source of filtered radiation. The 
studies on the ceramic structure were carried out using Philips SEM 515 scanning electron microscope. 
To assess the biocompatibility of porous ceramics, the adipose-derived MSCs have been used. MSCs were 
isolated by enzymatic method and cultured in DMEM:F12 supplemented with 2 mM L-glutamine and 10% FBS 
(“Sigma”, USA) and incubated with the use of Cell IQ® v2 MLF integrated continuous live cell imaging and 
analysis platform (CM Technologies). The third passage MSCs have been used for the experiments. Preliminarily, 
MSC culture compliance with minimal criteria was made for phenotype (flow cytometry) and differentiation 
potential (differentiation assays for adipocytes and osteoblasts) [5]. Prior to seeding over the implants, cell viability 
in suspension was assessed by Trypan blue staining. [6] To assess the cytotoxicity of the implants and the viability 
of cultured MSCs over their surfaces, cell combined double staining with fluorescein diacetate (FDA) and 
propidium iodide (PI) 24h after inoculation and 7 days after culturing was made [7]. Assessment of cytotoxicity was 
performed using Axio Observer A1 inverted fluorescent microscope (Carl Zeiss, Germany). For the further 
biocompatibility assessment, the MSC osteogenic differentiation assay was performed according to standard 
protocols [8]. MSCs were cultured in implants or over its surface for 14 days, followed by detection of alkaline 
phosphatase activity using the BCIP/NBT substrate (Sigma, USA) [9]. 
RESULTS AND DISCUSSION 
Powders. Figure 1(a) represents the SEM-picture of plasmachemically-synthesized ZrO2 powder (3 mol.% 
Y2O3) and the powder particle size distribution. ZrO2 (3 mol.% MgO) and ZrO2 (3 mol.% Y2O3) powders practically 
have no difference in morphological structure and they consist of hollow particles of a spherical shape and a large 
number of units having no regular form. The average particle size of the spherical ZrO2(MgO) and ZrO2(Y2O3) 
powders was 1.8 and 1.5 ?m, respectively. 
The phase composition of ZrO2(Y2O3) powder includes tetragonal and monoclinic ZrO2. The ZrO2(MgO) 
powder comprised the cubic, tetragonal and monoclinic phases of ZrO2. The fraction of tetragonal ZrO2 in 
ZrO2(Y2O3) powder amounted about 95%, while that of cubic ZrO2 in ZrO2(MgO) powder was 75%. The average 
size of the coherent scattering regions (CSR) of tetragonal ZrO2 in ZrO2(Y2O3) powder was 20 nm, and for the 
monoclinic modification it was 50 nm. The average size of CSR for cubic modification of ZrO2 in ZrO2(MgO) 
powder was 20 nm, for monoclinic ZrO2 it was 30 nm and for the tetragonal phase it was 15 nm. 
Sintered ceramics. Figure 2(a) represents the SEM-image of ZrO2(Y2O3) ceramic structure and the pore size 
distribution. The structure of ZrO2(MgO) and ZrO2(Y2O3) ceramics was represented by a cellular frame.  
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FIGURE 2. SEM-Picture of ZrO2 ceramics structure (Y2O3), the characteristic pore size distribution of ZrO2 ceramics (MgO) 
with a porosity of ?40% 
 
The cells were nearly spherical and the cell size exceeded many-fold the thickness of walls that were represented 
by a single-layer stack of ZrO2 grains. The pore size distribution was bimodal. The first maximum was formed by 
equiparticle pores, the voids that were not filled with powder particles during the compaction, and the second 
maximum was conditioned by the larger pores with a shape close to spherical. The plots presented in Fig. 2b 
demonstrates the dependence of the average size of equiparticle and large spherical pores on the porosity in 
ZrO2(MgO) and ZrO2(Y2O3) ceramics. It is clear that the increase of pore volume in the material from about 30 to 
80% achieved by reducing the sintering temperature of the samples was accompanied by the increase of the average 
size of large pores from 2 to 6 microns. Changing the porosity of the material had practically no effect on the 
average size of equiparticle pores having the average size of 0.5 microns. It can be assumed that the presence of 
large pores close to a spherical shape in the ceramics is conditioned by the presence of hollow spherical particles in 
the source powders, since their average size is commensurate with the average size of large pores occurring in the 
sintered material. 
Biocompatibility: cytotoxicity and osteogenic differentiation of MSCs/ Cultured adipose tissue-derived 
MSCs used for the preliminary assessment of the biocompatibility of porous ceramic implants had the capacity to 
differentiate in adipogenic and osteogenic directions and had the following phenotype: CD73+ CD90+ CD105+ and 
CD34- CD45-. Combined staining of FDA/PI cells cultured on the surface or in the implants showed no cytotoxicity 
of porous ZrO2 ceramics (Fig. 3). The results of the cell viability evaluation in suspension with the use of Trypan 
blue staining before seeding and 24h after culturing on implants by staining with FDA/PI exhibited similar values 
(suspension, Trypan blue, 96.42% ± 1.8% viable cells; implant, FDA/PI, 93.78% ± 2.15%). Microscopic observation 
showed that MSCs 24h after seeding adhered to the surface of the implant and generated intensive and uniform 
green FDA stain in the absence of red PI stain, which indicates a high metabolic activity of the cells and the integrity 
of their membrane. At the same time the cells had different spreading degree due to the rough surface of the implant 
through its physical structure (the presence of pores and composition of hollow particles of a spherical shape and a 
large number of units having no regular form).  
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FIGURE 3. Viability assessment of MSCs cultured on the porous surface of the ZrO2 ceramic implants: (a) 24h of culturing and 
(b) 7 days of culturing. Combined FDA/PI stain 349
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FIGURE 4. Detection of alkaline phosphatase activity after osteogenic differentiation of MSCs cultured on the porous ZrO2 
ceramic implants. BCIP/NBT stain 
 
Cell viability after 7 days of culturing with porous ZrO2 ceramic implants was 92.56% ± 1.44%, which is 
comparable to cell viability before seeding and after 24h culturing with implants (difference is not statistically 
significant). Moreover, after 7 days of MSC culturing on the surface of porous ZrO2 ceramics, the formation of cell 
clusters due to their proliferation was noted. Thus, porous ZrO2 ceramic implants do not have the acute and chronic 
cytotoxicity. Detection of alkaline phosphatase activity with use of BCIP/NBT substrate showed that cultured MSCs 
on the porous surface of ZrO2 ceramic implant retain their ability for osteogenic differentiation (Fig. 4). Based on 
the results of the osteogenic differentiation of MSCs, we can conclude that porous ZrO2 ceramic implants possess 
osteoconductive properties. 
CONCLUSIONS 
It was elucidated that the structure of ZrO2(MexOy) ceramics made of powders consisting of hollow spherical 
particles with the porosity of 30% is represented by a cellular framework with the bimodal porosity, formed by large 
pores with the shape close to spherical and pores that were not filled with the powder particles during the 
compaction. It was found that ZrO2(MexOy) ceramics with bimodal pore size distribution at the porosity exceeding 
30% demonstrate the micromechanical instability during the compaction, which is caused by the reversible 
deformation of the cellular elements. For the cases of such ceramics the increase of pore volume is accompanied by 
the increase of strain in the elastic area. It was also shown that the porous ZrO2 ceramics had no acute or chronic 
cytotoxicity. At the same time, the porous ZrO2 ceramics possess the osteoconductive properties: adhesion support, 
spreading, proliferation and osteogenic differentiation of MSCs. 
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